Environmental exposure to triclosan and polycystic ovary syndrome: a cross-sectional study in China

被引:14
|
作者
Ye, Jiangfeng [1 ]
Zhu, Wenting [2 ]
Liu, Han [3 ]
Mao, Yuchan [4 ]
Jin, Fan [2 ]
Zhang, Jun [3 ,5 ]
机构
[1] Fudan Univ, Inst Obstet & Gynecol, Obstet & Gynecol Hosp, Dept Clin Epidemiol, Shanghai, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Key Lab Womens Reprod Hlth Zhejiang Prov,Sch Med, Key Lab Reprod Genet,Minist Educ,Dept Reprod Endo, Hangzhou, Zhejiang, Peoples R China
[3] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Minist Educ,Shanghai Key Lab Childrens Environm H, Shanghai, Peoples R China
[4] Zhejiang Univ, Womens Hosp, Key Lab Womens Reprod Hlth Zhejiang Prov, Sch Med, Hangzhou, Zhejiang, Peoples R China
[5] Guilin Med Sch, Sch Publ Hlth, Guilin, Guangxi, Peoples R China
来源
BMJ OPEN | 2018年 / 8卷 / 10期
关键词
ENDOCRINE-DISRUPTING CHEMICALS; ANDROGENIC ACTIVITY; PHENOLS; TRICLOCARBAN; SYSTEM; WOMEN; RATS;
D O I
10.1136/bmjopen-2017-019707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of women at reproductive age. Although the aetiology of PCOS remains unclear, potential effects of environmental endocrine-disrupting compounds on the development of PCOS have drawn increasing attention. The aim of the current study was to examine the association between triclosan (TCS) and PCOS, and explore possible mechanisms on how TCS may contribute to the development of clinical manifestations of PCOS. Design Cross-sectional study. Setting This study was conducted in one tertiary-level hospital located in Zhejiang, China. Participants A total of 674 infertile women at 18-45 years of age were recruited in 2014-2015. Participants with (n=84) and without (n=212) PCOS with urinary TCS concentration available were included in the analyses. Methods Urinary TCS concentration was measured using a high-performance liquid chromatography-electrospray ionisation tandem mass spectrometry. Logistic regression model was used to examine the association between TCS and PCOS. Fractional polynomial regression models were built to fit the potential non-linear relationship between TCS concentrations and luteinising hormone (LH) and LH/follicle stimulate hormone (FSH). Results The PCOS group had significantly higher level of TCS concentration than the non-PCOS group (the median of TCS (IQR), mu g/g creatinine: 1.49 (0.68-3.80) vs 1.06 (0.52-3.02), p=0.0407). Compared with the lowest tertile, the highest tertile of TCS concentration was associated with an increased odd of PCOS (OR 2.12, 95% CI 1.12 to 3.99). After adjusting for potential confounders, the significant association remained (OR 1.99, 95% CI 1.05 to 3.79). Positive relationships were found between TCS levels and LH and LH/FSH ratio in non-PCOS participants. Conclusions TCS exposure at a relatively low level is associated with PCOS in Chinese women. Further epidemiological studies are needed to confirm our finding, which may have important public health implications.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Sexual Function in Women with Polycystic Ovary Syndrome Living in Stable Heterosexual Relationships: A Cross-Sectional Study
    Warchala, Anna
    Madej, Pawel
    Kochanowicz, Marta
    Krzystanek, Marek
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [42] Relationship of Myonectin with Insulin Resistance in Patients with Polycystic Ovary Syndrome A Cross-Sectional Prospective Clinical Study
    Korkmaz, Nazli
    Aydin, Alev Atis
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2021, 66 (7-8) : 183 - 188
  • [43] Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study
    Bedaiwy, Mohamed A.
    Abdel-Rahman, Mohamed Y.
    Tan, Justin
    AbdelHafez, Faten F.
    Abdelkareem, Amr O.
    Henry, Drisana
    Lisonkova, Sarka
    Hurd, William W.
    Liu, James H.
    [J]. JOURNAL OF WOMENS HEALTH, 2018, 27 (05) : 659 - 664
  • [44] The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study
    Abdalla, Mohammed Altigani
    Deshmukh, Harshal
    Mohammed, Irfaan
    Atkin, Stephen
    Reid, Marie
    Sathyapalan, Thozhukat
    [J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [45] Phenotypic Characterization of Patients with Polycystic Ovary Syndrome in a Population from the Ecuadorian Andes: A Cross-Sectional Study
    Espinosa, Maria Elena
    Sanchez, Raul
    Otzen, Tamara
    Bautista-Valarezo, Estefania
    Aguiar, Stephanie
    Corrales-Gutierrez, Isabel
    Leon-Larios, Fatima
    Manterola, Carlos
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [46] Body mass index, menstruation, acne, and hirsutism of polycystic ovary syndrome in women: A cross-sectional study
    Kim, Jung-Hee
    Kim, Oksoo
    Jung, Heeja
    Pang, Yanghee
    Dan, Hyunju
    [J]. HEALTH CARE FOR WOMEN INTERNATIONAL, 2022, 43 (1-3) : 85 - 97
  • [47] Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study
    Marina Sourouni
    Julia Estermann
    Norman Bitterlich
    Susanna Weidlinger
    Annette Bachmann
    Petra Stute
    [J]. Archives of Gynecology and Obstetrics, 2024, 309 : 2115 - 2126
  • [48] Association of insulin resistance with polycystic ovary syndrome phenotypes and patients’ characteristics: a cross-sectional study in Iran
    Leili Rahmatnezhad
    Lida Moghaddam-Banaem
    Tahereh Behroozi-Lak
    Afshin Shiva
    Javad Rasouli
    [J]. Reproductive Biology and Endocrinology, 21
  • [49] The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Koiou, Ekaterini
    Kandaraki, Eleni A.
    Tsourdi, Elena
    Delkos, Dimitrios
    Kalaitzakis, Emmanuil
    Katsikis, Ilias
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2010, 8
  • [50] Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study
    Betânia Rodrigues Santos
    Sheila Bunecker Lecke
    Poli Mara Spritzer
    [J]. Reproductive Biology and Endocrinology, 16